Healthequity Inc (HQY)

$104.65

+1.69

(+1.64%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $102.45
    $105.44
    $104.65
    downward going graph

    2.1%

    Downside

    Day's Volatility :2.84%

    Upside

    0.75%

    downward going graph
  • $62.10
    $105.48
    $104.65
    downward going graph

    40.66%

    Downside

    52 Weeks Volatility :41.13%

    Upside

    0.79%

    downward going graph

Returns

PeriodHealthequity IncSector (Health Care)Index (Russel 2000)
3 Months
39.25%
-6.9%
0.0%
6 Months
31.7%
-1.7%
0.0%
1 Year
56.73%
10.4%
0.0%
3 Years
72.24%
8.8%
-24.1%

Highlights

Market Capitalization
9.0B
Book Value
$24.70
Earnings Per Share (EPS)
1.2
PE Ratio
85.8
PEG Ratio
1.12
Wall Street Target Price
106.786
Profit Margin
9.61%
Operating Margin TTM
20.24%
Return On Assets TTM
3.4%
Return On Equity TTM
5.15%
Revenue TTM
1.1B
Revenue Per Share TTM
12.73
Quarterly Revenue Growth YOY
23.1%
Gross Profit TTM
490.1M
EBITDA
337.4M
Diluted Eps TTM
1.2
Quarterly Earnings Growth YOY
2.33
EPS Estimate Current Year
2.19
EPS Estimate Next Year
2.83
EPS Estimate Current Quarter
0.7
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    94%Buy
    5%Hold
    0
    0%Sell
Based on 18 Wall street analysts offering stock ratings for Healthequity Inc(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
16
16
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 2.04%

Current $104.65
Target $106.79

Company Financials

FY19Y/Y Change
Revenue
287.2M
↑ 25.15%
Net Income
73.9M
↑ 56.03%
Net Profit Margin
25.73%
↑ 5.1%
FY20Y/Y Change
Revenue
532.0M
↑ 85.21%
Net Income
39.7M
↓ 46.33%
Net Profit Margin
7.46%
↓ 18.27%
FY21Y/Y Change
Revenue
733.6M
↑ 37.89%
Net Income
8.8M
↓ 77.73%
Net Profit Margin
1.2%
↓ 6.26%
FY22Y/Y Change
Revenue
756.6M
↑ 3.13%
Net Income
-44.3M
↓ 601.35%
Net Profit Margin
-5.85%
↓ 7.05%
FY23Y/Y Change
Revenue
861.7M
↑ 13.9%
Net Income
-26.1M
↓ 40.97%
Net Profit Margin
-3.03%
↑ 2.82%
FY24Y/Y Change
Revenue
999.6M
↑ 16.0%
Net Income
55.7M
↓ 313.1%
Net Profit Margin
5.57%
↑ 8.6%
Q2 FY23Q/Q Change
Revenue
244.4M
↑ 4.53%
Net Income
4.1M
↓ 2058.85%
Net Profit Margin
1.67%
↑ 1.76%
Q3 FY23Q/Q Change
Revenue
243.5M
↓ 0.36%
Net Income
10.6M
↑ 158.45%
Net Profit Margin
4.34%
↑ 2.67%
Q4 FY23Q/Q Change
Revenue
249.2M
↑ 2.33%
Net Income
14.7M
↑ 38.67%
Net Profit Margin
5.89%
↑ 1.55%
Q1 FY24Q/Q Change
Revenue
262.4M
↑ 5.28%
Net Income
26.4M
↑ 79.68%
Net Profit Margin
10.05%
↑ 4.16%
Q2 FY24Q/Q Change
Revenue
287.6M
↑ 9.61%
Net Income
28.8M
↑ 9.29%
Net Profit Margin
10.02%
↓ 0.03%
Q3 FY24Q/Q Change
Revenue
299.9M
↑ 4.29%
Net Income
35.8M
↑ 24.33%
Net Profit Margin
11.94%
↑ 1.92%
FY19Y/Y Change
Total Assets
510.0M
↑ 38.16%
Total Liabilities
32.9M
↑ 43.92%
FY20Y/Y Change
Total Assets
2.6B
↑ 402.96%
Total Liabilities
1.5B
↑ 4560.07%
FY21Y/Y Change
Total Assets
2.7B
↑ 5.65%
Total Liabilities
1.3B
↓ 13.27%
FY22Y/Y Change
Total Assets
3.1B
↑ 14.65%
Total Liabilities
1.3B
↓ 5.77%
FY23Y/Y Change
Total Assets
3.1B
↓ 0.59%
Total Liabilities
1.2B
↓ 4.88%
FY24Y/Y Change
Total Assets
3.2B
↑ 2.42%
Total Liabilities
1.1B
↓ 5.4%
Q2 FY23Q/Q Change
Total Assets
3.0B
↓ 1.74%
Total Liabilities
1.1B
↓ 6.44%
Q3 FY23Q/Q Change
Total Assets
3.1B
↑ 1.04%
Total Liabilities
1.1B
↑ 0.04%
Q4 FY23Q/Q Change
Total Assets
3.1B
↑ 0.88%
Total Liabilities
1.1B
↓ 1.01%
Q1 FY24Q/Q Change
Total Assets
3.2B
↑ 4.62%
Total Liabilities
1.2B
↑ 8.68%
Q2 FY24Q/Q Change
Total Assets
3.2B
↑ 0.31%
Total Liabilities
1.1B
↓ 4.39%
Q3 FY24Q/Q Change
Total Assets
3.5B
↑ 8.25%
Total Liabilities
1.4B
↑ 18.17%
FY19Y/Y Change
Operating Cash Flow
113.4M
↑ 38.82%
Investing Cash Flow
25.7M
↓ 169.81%
Financing Cash Flow
22.9M
↑ 57.44%
FY20Y/Y Change
Operating Cash Flow
105.9M
↓ 6.67%
Investing Cash Flow
-1.7B
↓ 6885.02%
Financing Cash Flow
1.5B
↑ 6301.23%
FY21Y/Y Change
Operating Cash Flow
181.6M
↑ 71.57%
Investing Cash Flow
-97.0M
↓ 94.43%
Financing Cash Flow
52.4M
↓ 96.43%
FY22Y/Y Change
Operating Cash Flow
141.0M
↓ 22.37%
Investing Cash Flow
-639.2M
↑ 559.26%
Financing Cash Flow
394.9M
↑ 653.24%
FY23Y/Y Change
Operating Cash Flow
150.7M
↑ 6.85%
Investing Cash Flow
-119.1M
↓ 81.36%
Financing Cash Flow
-2.7M
↓ 100.68%
Q2 FY23Q/Q Change
Operating Cash Flow
31.5M
↓ 43.17%
Investing Cash Flow
-9.1M
↓ 11.1%
Financing Cash Flow
-51.0M
↑ 4352.62%
Q3 FY23Q/Q Change
Operating Cash Flow
77.1M
↑ 144.49%
Investing Cash Flow
-10.2M
↑ 12.19%
Financing Cash Flow
-2.2M
↓ 95.78%

Technicals Summary

Sell

Neutral

Buy

Healthequity Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Healthequity Inc
Healthequity Inc
19.45%
31.7%
56.73%
72.24%
71.7%
Solventum Corp
Solventum Corp
-4.1%
12.51%
0.77%
0.77%
0.77%
Doximity, Inc.
Doximity, Inc.
13.85%
71.25%
95.76%
-18.73%
-9.43%
Veeva Systems Inc.
Veeva Systems Inc.
-2.28%
4.27%
22.1%
-26.54%
39.98%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-8.18%
1.71%
11.41%
35.56%
35.56%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Healthequity Inc
Healthequity Inc
85.8
85.8
1.12
2.19
0.05
0.03
NA
24.7
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
57.36
57.36
2.42
0.9
0.19
0.12
NA
5.15
Veeva Systems Inc.
Veeva Systems Inc.
56.02
56.02
1.21
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.26
23.26
2.12
4.28
0.22
0.06
0.0
18.2
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Healthequity Inc
Healthequity Inc
Buy
$9.0B
71.7%
85.8
9.61%
Solventum Corp
Solventum Corp
Hold
$10.8B
0.77%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$9.3B
-9.43%
57.36
33.69%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.1B
39.98%
56.02
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$38.8B
35.56%
23.26
8.56%

Insights on Healthequity Inc

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 243.54M → 299.92M (in $), with an average increase of 5.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 11 quarters, -32.81M → 35.82M (in $), with an average increase of 167.0% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 95.8% return, outperforming this stock by 39.1%

Institutional Holdings

  • BlackRock Inc

    12.30%

  • Vanguard Group Inc

    10.16%

  • Wasatch Advisors LP

    8.33%

  • FMR Inc

    6.06%

  • State Street Corp

    3.56%

  • ClearBridge Advisors, LLC

    2.72%

Company Information

healthequity is the nation’s oldest and largest dedicated health savings trustee. we help individuals and families build health savings, while empowering employers to spend less on benefits through innovative, integrated health care account administration and investment platforms, all backed by 24/7/365 service, personalized savings strategies and consumer education. healthequity partners–more than 14,000 employers and 60 national health plans–spend less on benefits and get more by leveraging healthequity’s acclaimed service and education. healthequity is an irs-approved nonbank hsa trustee. as of september 30, 2010, healthequity manages more than $640 million in health savings assets. and all healthequity-managed cash deposits are fdic-insured to the greatest extent allowed by law. founded by dr. stephen neeleman, a practicing trauma surgeon and author of the complete hsa guidebook, healthequity is based in salt lake city and has members and sales representatives nationwide. v

Organization
Healthequity Inc
Employees
3126
CEO
Mr. Jon Kessler
Industry
Finance

FAQs